Genomic stability of self-complementary adeno-associated virus 2 during early stages of transduction in mouse muscle in vivo

Human Gene Therapy

Volumn 16, Issue 9, 2005, Pages 1047-1057

  Ren, Changchun ^a   Kumar, Sanjay ^a   Shaw, Denise R ^b   Ponnazhagan, Selvarangan ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; DIMER; GREEN FLUORESCENT PROTEIN; MONOMER; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 2; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DNA ISOLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; GENE STRUCTURE; GENETIC TRANSDUCTION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUADRICEPS FEMORIS MUSCLE; QUANTITATIVE ANALYSIS; SOUTHERN BLOTTING; TRANSGENE; VIRAL GENE THERAPY; VIRUS CAPSID; VIRUS GENOME; VIRUS PARTICLE; VIRUS RECOMBINANT;

ANIMALS; CELL LINE; CELL LINE, TUMOR; DEPENDOVIRUS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE THERAPY; GENETIC VECTORS; GENOMIC INSTABILITY; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MUSCLE, SKELETAL; POLYMERASE CHAIN REACTION; TRANSDUCTION, GENETIC; TRANSGENES;

ADENO-ASSOCIATED VIRUS 2; MIRIDAE;

EID: 24944453047     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2005.16.1047     Document Type: Article

References (32)

1. CHEN, Z.Y., YANT, S.R., HE, C.Y., MEUSE, L., SHEN, S., and KAY, M.A. (2001). Linear DNAs concatemerize in vivo and result in sustained transgene expression in mouse liver. Mol. Ther. 3, 403-410.
2. DING, W., YAN, Z., ZAK, R., SAAVEDRA, M., RODMAN, D.M., and ENGELHARDT, J.F. (2003). Second-strand genome conversion of adeno-associated virus type 2 (AAV-2) and AAV-5 is not rate limiting following apical infection of polarized human airway epithelia. J. Virol. 77, 7361-7366.
3. DUAN, D., SHARMA, P., YANG, J., YUE, Y., DUDUS, L., ZHANG, Y., FISHER, K.J., and ENGELHARDT, J.F. (1998). Circular intermediates of recombinant adeno-associated virus have defined structural characteristics responsible for long-term episomal persistence in muscle tissue. J. Virol. 72, 8568-8577.
4. DUAN, D., YAN, Z., YUE, Y., and ENGELHARDT, J.F. (1999). Structural analysis of adenoassociated virus transduction intermediates. Virology 261, 18-14.
5. DUAN, D., YUE, Y., YAN, Z., and ENGELHARDT, J.F. (2000). A new dual-vector approach to enhance recombinant adeno-associated virus-mediated gene expression through intermolecular cis activation. Nat. Med. 6, 595-598.
6. DUAN, D., YUE, Y., and ENGELHARDT, J.F. (2003). Consequences of DNA-dependent protein kinase catalytic subunit deficiency on recombinant adeno-associated virus genome circularization and heterodimerization in muscle tissue. J. Virol. 77, 4751-4759.
7. FERRARI, F.K., SAMULSKI, T., SHENK, T., and SAMULSKI, R.J. (1996). Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors. J. Virol. 70, 3227-3234.
8. FISHER, K.J., GAO, G.P., WEITZMAN, M., DEMATTEO, D.R., BURDA, J. F., and WILSON, J.M. (1996). Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
9. FISHER, K.J., JOOSS, K., ALSTON, J., YANG, Y., HAECKER, S.E., HIGH, K., PATHAK, R., RAPER, S.E., and WILSON, J.M. (1997). Recombinant adeno-associated virus for muscle directed gene therapy. Nat. Med. 3, 306-312.
10. GRIMM, D., KERN, A., RITTNER, K., and KLEINSCHMIDT, J.A. (1998). Novel tools for production and purification of recombinant adeno associated virus vectors. Hum. Gene Ther. 9, 2745-2760.
11. HAUCK, B., ZHAO, W., HIGH, K., and XIAO, W. (2004). Intracellular viral processing, not single-stranded DNA accumulation is crucial for recombinant adeno-associated virus transduction. J. Virol. 78, 13678-13686.
12. MARCUS-SEKURA, C., and CARTER, B.J. (1983). Chromatin-like structure of adeno-associated virus DNA in infected cells. J. Virol. 48, 79-87.
13. MCCARTY, D.M., MONAHAN, P.E., and SAMULSKI, R.J. (2001). Self-complementary recombinant adeno-associated virus (scAAV) vectors promote efficient transduction independently of DNA synthesis. Gene Ther. 8, 1248-1254.
14. MCCARTY, D.M., FU, H., MONAHAN, P.E., TOULSON, C.E., NAIK, P., and SAMULSKI, R.J. (2003). Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo. Gene Ther. 10, 2112-2118.
15. MIAO, C.H., SNYDER, R.O., SCHOWALTER, D.B., PATIJN, G.A., DONAHUE, B., WINTHER, B., and KAY, M.A. (1998). The kinetics of rAAV integration in the liver. Nat. Genet. 19, 13-15.
16. MIAO, C.H., NAKAI, H., THOMPSON, A.R., STORM, T.A., CHIU, W., SNYDER, R.O., and KAY, M.A. (2000). Nonrandom transduction of recombinant adeno-associated virus vectors in mouse hepatocytes in vivo: Cell cycling does not influence hepatocyte transduction. J. Virol. 74, 3793-3803.
17. NAKAI, H., STORM, T.A., and KAY, M.A. (2000a). Increasing the size of rAAV-mediated expression cassettes in vivo by intermolecular joining of two complementary vectors. Nat. Biotechnol. 18, 527-532.
18. NAKAI, H., STORM, T.A., and KAY, M.A. (2000b). Recruitment of single-stranded recombinant adeno-associated virus vector genomes and intermolecular recombination are responsible for stable transduction of liver in vivo. J. Virol. 74, 9451-9463.
19. NAKAI, H., YANT, S.R., STORM, T.A., FUESS, S., MEUSE, L., and KAY, M.A. (2001). Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969-6976.
20. PONNAZHAGAN, S., MAHENDRA, G., LIMA, J., ALDRICH, W.A., JENKINS, C.B., REN, C., KUMAR, S., KALLMAN, L., STRONG, T.V., SHAW, D.R., and TRIOZZI, P.L. (2004a). Augmentation of antitumor activity of a recombinant adeno-associated virus carcinoembryonic antigen vaccine with plasmid adjuvant. Hum. Gene Ther. 15, 856-864.
21. PONNAZHAGAN, S., MAHENDRA, G., KUMAR, S., SHAW, D.R., STOCKARD, C.R., GRIZZLE, W.E., and MELETH, S. (2004b). Adeno-associated virus 2-mediated antiangiogenic cancer gene therapy: Long-term efficacy of a vector encoding angiostatin and endostatin over vectors encoding a single factor. Cancer Res. 64, 1781-1787.
22. RAJ, K., OGSTON, P., and BEARD, P. (2001). Virus-mediated killing of cells that lack p53 activity. Nature 412, 914-917.
23. SRIVASTAVA, A., LUSBY, E.W., and BERNS, K.I. (1983). Nucleotide sequence and organization of the adeno-associated virus 2 genome. J. Virol. 45, 555-564.
24. SUN, L., LI, J., and XIAO, X. (2000). Overcoming adeno-associated virus vector size limitation through viral DNA heterodimerization. Nat. Med. 6, 599-602.
25. THEISS, H.D., KOFLER, D.M., BUNING, H., ALDENHOFF, A.L., KAESS, B., DECKER, T., BAUMERT, J., HALLEK, M., and WENDTNER, C.M. (2003). Enhancement of gene transfer with recombinant adeno-associated virus (rAAV) vectors into primary B-cell chronic lymphocytic leukemia cells by CpG-oligodeoxynucleotides. Exp. Hematol. 31, 1223-1229.
26. THOMAS, C.E., STORM, T.A., HUANG, Z., and KAY, M.A. (2004). Rapid uncoating of vector genomes is the key to efficient liver transduction with pseudotyped adeno-associated virus vectors. J. Virol. 78, 3110-3122.
27. VINCENT-LACAZE, N., SNYDER, R.O., GLUZMAN, R., BOHL, D., LAGARDE, C., and DANOS, O. (1999). Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol. 73, 1949-1955.
28. WANG, Z., MA, H.I., LI, J., SUN, L., ZHANG, J., and XIAO, X. (2003). Rapid and highly efficient transduction by double-stranded adeno-associated virus vectors in vitro and in vivo. Gene Ther. 10, 2105-2111.
29. XIAO, X., LI, J., and SAMULSKI, R.J. (1996). Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector. J. Virol. 70, 8098-8108.
30. YANG, J., ZHOU, W., ZHANG, Y., ZIDON, T., RITCHIE, T., and ENGELHARDT, J.F. (1999). Concatemerization of adeno-associated virus circular genomes occurs through intermolecular recombination. J. Virol. 73, 9468-9477.
31. YUE, Y., and DUAN, D. (2003). Double strand interaction is the pre-dominant pathway for intermolecular recombination of adeno-associated viral genomes. Virology 313, 1-7.
32. ZOLOTUKHIN, S., BYRNE, B.J., MASON, E., ZOLOTUKHIN, I., POTTER, M., CHESNUT, K., SUMMERFORD, C., SAMULSKI, R.J., and MUZYCZKA, N. (1999). Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther. 6, 973-985.